The company, which first signed on to provide services to the VA's Million Veteran Program in 2013, will provide the department with 34,000 more genomes.
The firm plans to develop and evaluate the utility of an ethnically diverse group of metastatic prostate cancer patient-derived xenograft models.
Scotland's Arrayjet will provide the Bronx-based NYBC with microarray instrumentation, printing, and expertise under an approximately $250,000 contract.
The company will work with researchers from the University of North Texas Health Science Center to develop better software for forensics.
Stat News examines ethical questions raised by Alphabet's Verily awarding a research contract to a clinic mostly owned by its CEO.
Genomics England has selected WuXi Nextcode to interpret genomic data from cancer and rare disease samples as part of the UK 100K Genomes Project.
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
CDI Laboratories will use Arrayjet's Ultra Marathon II instrument to print its proteomics and other custom microarrays.
N-of-One will provide clinical interpretation services for genomic tests conducted as part of the New England Veterans' Integrated Service Network oncology program
Helomics' tumor profiling products and services, including ChemoFx, will be available to more than 700,000 Prime Health Services providers.
The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.
The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.